OCAI
OACC

O'Connor Alternative Investments’s Oaktree Acquisition Corp III Life Sciences OACC Stock Holding History

O'Connor Alternative Investments’s Portfolio OACC Stock Details OACC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.21M Hold
300,000
– – 0.23% 36
2026
Q1 		$3.17M Buy
+300,000
New +$3.19M 0.17% 38

Other funds holding OACC

FBCM
Fort Baker Capital Management Larkspur, California $1.37B AUM 26.9% 1-Year Est. Return
DAM
Decagon Asset Management London, United Kingdom $525M AUM 50.51% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
LA
Linden Advisors New York $19.3B AUM 1.46% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
SC
Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
MCM
Moore Capital Management New York $6.74B AUM 45.87% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $26.8B AUM 68.39% 1-Year Est. Return
AIMCA
Alberta Investment Management Corp (AIMCo) Edmonton, Alberta, Canada $17.9B AUM 27.57% 1-Year Est. Return

O'Connor Alternative Investments's OACC Position: Q2 2026 in Review

O'Connor Alternative Investments held its Oaktree Acquisition Corp III Life Sciences (OACC) position steady in Q2 2026 at 300,000 shares worth $3.21M. The position accounts for 0.23% of the portfolio, ranked #36.

O'Connor Alternative Investments first reported a position in OACC in Q1 2026 and has held it in 2 quarters since. 41 funds tracked by Wall St. Rank hold OACC as of Q2 2026.

  • O'Connor Alternative Investments held 300,000 shares of Oaktree Acquisition Corp III Life Sciences worth $3.21M as of Q2 2026.
  • O'Connor Alternative Investments left its Oaktree Acquisition Corp III Life Sciences share count unchanged in Q2 2026.
  • Oaktree Acquisition Corp III Life Sciences made up 0.23% of O'Connor Alternative Investments's portfolio in Q2 2026, its #36 holding.
  • O'Connor Alternative Investments first reported a position in Oaktree Acquisition Corp III Life Sciences in Q1 2026 and has held it in 2 quarters since.
  • 41 funds tracked by Wall St. Rank held Oaktree Acquisition Corp III Life Sciences as of Q2 2026.

Based on O'Connor Alternative Investments's 13F filing for Q2 2026, filed 14 Aug 2026.